Madrigal pharmaceuticals reports first-quarter 2024 financial results and provides corporate updates

Conshohocken, pa., may 07, 2024 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq:mdgl), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (nash), today reports first-quarter 2024 financial results and provides corporate updates.

MDGL Ratings Summary

MDGL Quant Ranking